Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Adherence to attendance at outpatient clinic, quality of prehospital therapy, and direct outcome of acute coronary syndrome: analysis within LIS-3 registry

https://doi.org/10.20996/1819-6446-2016-12-4-430-434

Full Text:

Abstract

Aim. To assess the influence of patients’ adherence to attendance at outpatient clinics (OPC) on direct outcome of acute coronary syndrome (ACS).

Material and methods. Patients (n=320) hospitalized with ACS were divided into 3 groups depending on their attendance at OPC before ACS: group A - committed to attending OPC (n=139); group B - partially committed to attending OPC (n=103); group C - non-committed to attending OPC (n=78). Direct outcome of ACS and its connection to attendance at OPC was analyzed. The primary end point of the study was the development of myocardial infarction or unstable angina as direct outcome of ACS.

Results. The majority of patients had myocardial infarction as direct outcome ofACS.Development of myocardial infarctionwas aboutthe same in3groups of attendance at OPC (p=0.158). Influence of patients’ adherence to attendance at OPC on direct outcome of ACS was not found (RR=0.602, р=0.123). History of ischemic heart disease and myocardial infarction didn’t change this predicted pattern. In the absence of significant influence of patients' adherence to attendance at OPC on the direct ACS outcome, it was decided to evaluate the effect of pre-hospital care quality on direct outcome of ACS, regardless of patients’ adherence to attendance at OPC. Quality of pre-hospital therapy was low, but therapy of patients with unstable angina as an outcome of ACS was significantly better than therapy of patients with myocardial infarction as an outcome of ACS. Taking antiplatelet agents, beta-blockers and long-acting nitrates before ACS development significantly reduced the risk of myocardial infarction as an outcome of the ACS.

Conclusion. Patients’ adherence to attendance at OPC didn’t influence direct outcome of ACS by itself, even considering the history of ischemic heart disease and myocardial infarction. Quality of pre-hospital therapy of patients with unstable angina as an outcome of ACS was significantly better than therapy of patients with myocardial infarction as an outcome of ACS. This is especially true in terms of drugs with proven effects on disease outcome. Taking antiplatelet agents, beta-blockers and long-acting nitrates before ACS development significantly reduces the risk of myocardial infarction as an outcome of the ACS

About the Authors

Yu. V. Semenova
State Research Centre for Preventive Medicine
Russian Federation
Petroverigsky per. 10, Moscow, 101990


N. P. Kutishenko
State Research Centre for Preventive Medicine
Russian Federation
Petroverigsky per. 10, Moscow, 101990


A. V. Zagebelnyy
State Research Centre for Preventive Medicine
Russian Federation
Petroverigsky per. 10, Moscow, 101990


A. D. Deev
State Research Centre for Preventive Medicine
Russian Federation
Petroverigsky per. 10, Moscow, 101990


M. L. Ginzburg
Lyubertsy Regional Hospital №2
Russian Federation
Oktyabr’skiy prospect 338, Moscow Region, Lyubertsy, 140006


S. Yu. Martsevich
State Research Centre for Preventive Medicine
Russian Federation
Petroverigsky per. 10, Moscow, 101990


References

1. Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33(20):2569-619.

2. Lozhkina NG, MaksimovVN, KuimovAD, et al. Prediction of outcome of acute coronary syndrome. Sovremennye Problemy Nauki i Obrazovaniya 2013; (4): 44. In Russian (Ложкина НГ, Максимов ВН, КуимовАД, и др.Проблемыпрогнозирования исходов острого коронарного синдрома. Современные Проблемы Науки и Образования 2013;(4): 44).

3. Yellon DM, Baxter GF, Marber MS. Angina reassessed: pain or protector? Lancet (London, England) 1996;347(9009):1159-62.

4. Karpova ES, Kotelnikova EV, Lyamina NP. Ischemic preconditioning and its cardio protective effect in postintervention cardiac rehabilitation programs for patients with coronary heart disease. Russ J Cardiol 2012, 4 (96): 104-8. In Russian (Карпова ЭС, Котельникова ЕВ, Лямина НП. Ишемическое прекондиционирование и его кардиопротективный эффект в программах кардиореабилитации больных с ишемической болезнью сердца после чрескожных коронарных вмешательств. Российский Кардиологический Журнал 2012;4(96):104-8).

5. Verin VV, Selutin SM, Kachalov SN. Collateral circulation in coronary atherosclerosis. Dal'nevostochnyy Meditsinskiy Zhurnal 2011;(2):121-6. In Russian (Верин ВВ, Селютин СМ, Качалов СН. Коллатеральный коронарный кровоток при атеросклерозе венечных артерий. Дальневосточный Медицинский Журнал 2011;(2):121-6).

6. Kalinskaya AI, Urazovskaya IL, Vasilieva EU, Shpektor AV. Spontaneous reperfusion in ST-elevation myocardial infarction. Kreativnaya Kardiologiya 2012;(1):19-25. In Russian (Калинская АИ, Уразовская ИЛ, Васильева ЕЮ, Шпектор АВ. Спонтанный тромболизис у больных с острым инфарктом миокарда с подъемом сегмента ST. Креативная Кардиология 2012;(1):19-25).

7. Roffi M, Patrono C, Collet J-P, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2015;37(3):267-315.

8. Marcevich SY, Ginzburg ML, Kutishenko NP, et al. The LIS study (Lyubertsy study of mortality in patients with acute myocardial infarction). Evaluation of the pharmacotherapy. Part 1. Treatment of patients before myocardial infarction and its influence on hospital mortality rate. Rational Pharmacotherapy in Cardiology 2012; 8(5): 681-4. In Russian (Марцевич СЮ, Гинзбург МЛ, Кутишенко НП и др. ИсследованиеЛИС (Люберецкое исследование смертности больных, перенесших острый инфаркт миокарда). Оценка лекарственной терапии. Часть 1. Как лечатся больные перед инфарктом миокарда, и как это влияет на смертность в стационаре. Рациональная Фармакотерапия в Кардиологии 2012;8(5):681-4).

9. Marcevich SY, Ginzburg ML, Kutishenko NP, et al. The LIS study (Lyubertsy study on mortality rate in patients after acute myocardial infarction). Evaluation of drug therapy. Part 2. Influence of previous drug treatment on long-term life prognosis. Rational Pharmacotherapy in Cardiology 2012;8(5):738-45. In Russian (Марцевич СЮ, Гинзбург МЛ, Кутишенко НП и др. Исследование ЛИС (Люберецкое исследование смертности больных, перенесших острый инфаркт миокарда). Оценка лекарственной терапии. Часть 2. Влияние предшествующей лекарственной терапии на отдаленный прогноз жизни больных. Рациональная Фармакотерапия в Кардиологии 2012;8(5):738-45).

10. Marcevich SY, Kutishenko NP, Tolpygina SN, Lukina JV. National Guidelines for the efficacy and safety of drug therapy for primary and secondary prevention of cardiovascular disease. Kardiovaskulyarnaya Terapiya i Profilaktika 2011;7(5):1-72. In Russian (Марцевич СЮ, Кутишенко НП, Толпыгина СН, Лукина ЮВ. Национальные рекомендации по эффективности и безопасности лекарственной терапии при первичной и вторичной прифилактике сердечно-сосудистых заболеваний. Кардиоваскулярная Терапия и Профилактика 2011;7(5):1-72).

11. Semenova YuV, Kutishenko NP, Martsevich SYu. Analysis of the problem of low adherence of patients to attendance at outpatient clinics and cardiorehabilitation programs according to the data from published studies. Rational Pharmacotherapy in Cardiology 2015; 11(6): 618-25. In Russian (Семенова ЮВ, Кутишенко НП, Марцевич СЮ. Анализ проблемы низкой приверженности пациентов к посещению амбулаторных учреждений и программ крдиореабилитации по данным опубликованных исследований. Рациональная Фармакотерапия в Кардиологии 2015;11(6):618-25).

12. Martsevich SYu, Semenova YuV, Kutishenko NP, et al. Assessment of patients compliance for ambulatory institutions visits and its influence on the quality of treatment before development of acute coronary syndrome, by the LIS-3 registry. Russ J Cardiol 2016; 6 (134): 55-60. In Russian (Марцевич СЮ, Семенова ЮВ, Кутишенко НП, и др. Оценка приверженности пациентов к посещению лечебно-профилактических учреждений и ее влияния на качество терапии до развития острого коронарного синдрома в рамках регистра ЛИС-3. Российский Кардиологический Журнал 2016;134(6):55-60).

13. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009;119(23):3028-35.

14. Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm 2006;12(3):239-45.

15. Rasmussen JN, ChongA,AlterDA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 2007;297(2):177-86.

16. Gehi AK, Ali S, Na B, Whooley MA. Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Intern Med 2007;167(16):1798-803.

17. Ho PM, Magid DJ, Shetterly SM, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J 2008;155(4):772-9.

18. Taylor RS, Brown A, Ebrahim S, et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 2004;116(10):682-92.


For citation:


Semenova Y.V., Kutishenko N.P., Zagebelnyy A.V., Deev A.D., Ginzburg M.L., Martsevich S.Y. Adherence to attendance at outpatient clinic, quality of prehospital therapy, and direct outcome of acute coronary syndrome: analysis within LIS-3 registry. Rational Pharmacotherapy in Cardiology. 2016;12(4):430-434. (In Russ.) https://doi.org/10.20996/1819-6446-2016-12-4-430-434

Views: 393


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)